Innovative solutions to the greatest challenges in pharmaceutical development

11th – 13th March 2019 | Berlin

The perfect mix. The DDF Summit brings together leading formulation development and drug delivery scientists from both industry and academia to share and discuss their latest work.

Quality content. The agenda is packed with carefully selected talks on topics as diverse as the challenges you face.

Invaluable networking. The DDF community is open, friendly and represents and incredibly valuable network of scientists working at the forefront of their field. There is ample networking time built in to help you make and strengthen connections.

Tailor your experience. 4 parallel streams give you the chance to personalise your agenda and delve deep into the topics pertinent to your challenges. Choose from Small Molecules, Biologics, Technology & Innovation or Device Development.

The right size. This year the DDF Summit will be limited to just 500 people, in order to maintain the quality of the networking and comfort for participants. This means that there will only be 250 delegate tickets available. So, don’t waste time in getting yours.

Key themes for 2019 include:

  • The latest analytical techniques for improved formulation processes
  • The benefits and challenges of nanoparticle formulations
  • Human factors in device and combination product development
  • Overcoming the blood-brain barrier
  • Analysing the stability of biopharmaceutical excipients

Have a look at the full agenda here.

2018 POST EVENT REPORT

Speakers

Mostafa Nakach

Sanofi

Head of Pharmaceutical Engineering

Kerstin Walke

Boehringer Ingelheim

Head of Pharmaceutical Development Biologicals

Patrick Garidel

Boehringer Ingelheim

Associate Director Protein Science

Olaf Queckenberg

Bayer

Head of Chemical & Pharmaceutical Development

Jacqueline Maximilien

Janssen 

Senior Scientist

Harivardhan-Reddy Lakkireddy

Sanofi

Head of Drug Delivery Technologies & Innovation - Nanotechnologies

Prof. Dr. Robert Luxenhofer

Wuerzburg University

Chair of Chemical Technology of Materials Synthesis

James Meehan

AstraZeneca

Associate Principal Scientist – Human Factors

Heloise Audat

Sanofi

Head of Late Stage Formulation Development Unit, Biologics

Prof Rainer Jordan

TU Dresden

Professor of Macromolecular Chemistry

Ben Van Hove

Janssen

Associate Director Drug Product Development, Oral Solid Dosage Forms

Rémy Vomscheid

Ipsen

Director, Device Development & Technologies

Stephanie Greco

Sanofi

Head of laboratory in Pharmaceutical Engineering

Marc-Antoine Fabre

Sanofi

Global Head Biopharmacy

Jesper Lau

Novo Nordisk

Vice President, Protein and Peptide Chemistry

Samuel Kyeremateng

Abbvie

NCE Formulation Sciences Senior Scientist

Steve Bowman

Shire

Device Program Lead

Sachin Dubey

Glenmark

Head of Formulation and Analytical Development

Anacelia Ríos Quiroz

Roche

Scientist - Group Leader Particle Lab Biologics

Alessandro Fioni

Chiesi

DMPK Senior Scientist

Sune Andersen

Janssen

Principal Scientist Spray Drying

Advait Badkar

Pfizer

Senior Director

Alan S Harris

Ferring

Senior VP, Global R&D Life Cycle Management

Johannes Khinast

Research Center Pharmaceutical Engineering

Director

Anette Müllertz

University of Copenhagen

Professor, Head of Center

Satya Krishna Kishore Ravuri

Roche

Senior Group Leader, Early-Stage Pharmaceutical and Processing Development

Birger Brodin

University of Copenhagen

Faculty of Health and Medical Sciences Department of Pharmacy CNS Drug Delivery and Barrier Modelling

Mark R.H. Krebs

Janssen

Head of Formulation Development

Thomas Hoeg-Jensen

Novo Nordisk

Scientific Director

Corinna Sonderegger

Novartis

Head Portfolio Management Device Development & Commercialization

Daniel Latham

Novartis

Head – Device Development & LCM Device Development & Commercialisation

Simon Bjerregaard

Ferring

Senior Research Scientist

Gerhard Wenz

Saarland University

Professor

Marc Du Jardin

Janssen

Associate Director

Dr. Martin Hülsmeyer

AbbVie

Head of HTS Operations & Analytics NBE Formulation Sciences, Principal Research Scientist

Sabine Eichling

AbbVie

Senior Scientist II, NBE High Throughput and Advanced Formulation Sciences Drug Product Development